MyFinsight
Home
Blog
About
Cash and cash
equivalents
$23,480K
(6.30%↑ Y/Y)
Prepaid expenses and
other current assets
$2,005K
(293.14%↑ Y/Y)
Total current assets
$25,485K
(12.78%↑ Y/Y)
Operating lease,
right-of-use assets
$4,292K
(-18.29%↓ Y/Y)
Other long-term
prepaid assets
$825K
(37.50%↑ Y/Y)
Restricted cash,
noncurrent
$515K
(-26.43%↓ Y/Y)
Property and equipment,
net
$213K
(-43.50%↓ Y/Y)
Total assets
$31,330K
(6.10%↑ Y/Y)
Total liabilities and
stockholders' equity
$31,330K
(6.10%↑ Y/Y)
Total liabilities
$23,393K
(-15.53%↓ Y/Y)
Total stockholders'
equity
$7,937K
(332.77%↑ Y/Y)
Accumulated deficit
-$253,712K
(-17.53%↓ Y/Y)
Treasury stock, at cost,
14,455 shares...
$150K
(0.00%↑ Y/Y)
Accumulated other
comprehensive loss
-$126K
(-80.00%↓ Y/Y)
Long-term debt, net
$9,535K
(2.12%↑ Y/Y)
Total current
liabilities
$9,202K
(-7.27%↓ Y/Y)
Operating lease
liability, noncurrent
$3,540K
(-23.26%↓ Y/Y)
Warrant liabilities
$1,116K
(-70.79%↓ Y/Y)
Additional paid-in capital
$261,706K
(20.18%↑ Y/Y)
Common stock, 0.01 par
value per share...
$219K
(34.36%↑ Y/Y)
Accrued expenses
$7,290K
(42.77%↑ Y/Y)
Operating lease
liability, current
$1,073K
(212.71%↑ Y/Y)
Accounts payable
$839K
(-78.29%↓ Y/Y)
Back
Back
Balance Sheet
Elicio Therapeutics, Inc. (ELTX)
Elicio Therapeutics, Inc. (ELTX)
source: myfinsight.com